Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Short term Debt (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Short term Debt for 9 consecutive years, with $25.2 million as the latest value for Q1 2026.

  • For Q1 2026, Short term Debt fell 11.17% year-over-year to $25.2 million; the TTM value through Mar 2026 reached $25.2 million, down 11.17%, while the annual FY2025 figure was $24.2 million, 19.48% up from the prior year.
  • Short term Debt hit $25.2 million in Q1 2026 for Select Medical Holdings, up from $24.2 million in the prior quarter.
  • Across five years, Short term Debt topped out at $113.9 million in Q1 2023 and bottomed at $20.3 million in Q4 2024.
  • Average Short term Debt over 5 years is $42.8 million, with a median of $42.8 million recorded in 2024.
  • Year-over-year, Short term Debt surged 364.63% in 2023 and then tumbled 70.57% in 2024.
  • Select Medical Holdings' Short term Debt stood at $44.4 million in 2022, then soared by 55.29% to $68.9 million in 2023, then crashed by 70.57% to $20.3 million in 2024, then increased by 19.48% to $24.2 million in 2025, then rose by 4.0% to $25.2 million in 2026.
  • According to Business Quant data, Short term Debt over the past three periods came in at $25.2 million, $24.2 million, and $28.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.